CVS Health Corporation’s Performance Outlook for the Coming Months

Trending News 🌥️

CVS ($NYSE:CVS) Health Corporation is a healthcare company that operates pharmacies, retail clinics, and specialty pharmacies. The company is headquartered in Woonsocket, Rhode Island. CVS Health Corporation’s stock is traded on the New York Stock Exchange under the ticker symbol “CVS.” In the last trading session, 1.62 million shares changed hands as the company’s beta touched 0.70.

The company’s stock has been on a bit of a roller coaster ride in recent months, but analysts believe that the company’s performance will improve in the coming months. Looking ahead, CVS Health Corporation is expected to benefit from the recently enacted tax reform legislation. Overall, analysts are bullish on CVS Health Corporation’s outlook for the coming months.

Price History

The company’s stock opened at $91.9 on Wednesday and closed at $91.7, down by 0.3% from its previous close of $91.9. Looking ahead, analysts are optimistic about the company’s performance in the coming months. They believe that CVS Health‘s recent acquisitions and initiatives will help drive growth and boost shareholder value.

In particular, analysts are bullish on the company’s prospects for its new prescription drug home delivery service, which is expected to launch later this year. Thanks to its diversified business model and solid financial position, the company is well-equipped to weather any challenges that may come its way.

VI Analysis

A company’s fundamentals are a reflection of its long-term potential. The VI app makes it easy to analyze a company’s financial and business risk. According to the VI Risk Rating, CVS HEALTH is a medium risk investment.

The app has detected 3 risk warnings in the income sheet, balance sheet, and non-financial areas. Become a registered user to check it out.

VI Peers

The competition between CVS Health Corp and its competitors is fierce. Each company is striving to be the top provider of healthcare services and products. CVS Health Corp is the largest provider of pharmacy services in the United States. Marpai Inc is a close second. Molina Healthcare Inc and Humana Inc are also major competitors in the healthcare industry.

– Marpai Inc ($NASDAQ:MRAI)

Marpai Inc is a publicly traded company with a market capitalization of 20.89 million as of 2022. The company has a return on equity of -64.66%. Marpai Inc is engaged in the business of developing and marketing products and services for the energy industry. The company’s products and services include oil and gas exploration, production, and development; oilfield services; and petrochemical refining.

– Molina Healthcare Inc ($NYSE:MOH)

Molina Healthcare Inc is a health care company that provides Medicaid-related solutions for low-income families and individuals. As of 2022, the company had a market capitalization of 20.52 billion dollars and a return on equity of 24.89%. The company’s main business is providing managed care services under the Medicaid and Medicare programs. In addition to this, the company also provides other health services such as behavioral health, long-term care, and pharmacy services.

– Humana Inc ($NYSE:HUM)

Humana Inc is a healthcare company that offers a wide range of health and wellness products and services. The company has a market cap of 63.3B as of 2022 and a return on equity of 17.4%. Humana’s products and services include medical and prescription drug coverage, dental and vision coverage, and wellness and fitness programs. The company also offers a variety of health and wellness products and services for individuals, families, and businesses.

Summary

The company offers a wide range of pharmacy and healthcare services, including prescription drugs, over-the-counter medications, immunizations, and health screenings. CVS Health has a long history of dividend growth, and the company’s shares have outperformed the market in recent years. Despite this strong track record, CVS Health‘s shares currently trade at a discount to the market. This presents an attractive opportunity for investors looking for a high-quality company with a history of dividend growth. CVS Health‘s business is well-positioned for growth in the coming years. The company’s pharmacy business should benefit from the continued expansion of its retail footprint and the continued growth of its pharmacy benefit management business.

In addition, CVS Health‘s walk-in clinics and MinuteClinics offer convenient and cost-effective healthcare services that are in high demand. The company’s shares currently trade at a discount to the market, making it an attractive investment option for long-term investors.